Cancer is one of the leading causes of death worldwide. The development of cancer-specific diagnostic agents and anticancer toxins would improve patient survival. The current and standard types of medical care for cancer patients, including surgery, radiotherapy, and chemotherapy, are not able to treat all cancers. A new treatment strategy utilizing tumor targeting peptides to selectively deliver drugs or applicable active agents to solid tumors is becoming a promising approach. In this review, we discuss the different tumor-homing peptides discovered through combinatorial library screening, as well as native active peptides. The different structure-function relationship data that have been used to improve the peptide's activity and conjuga...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Peptide therapeutics is a promising field for emerging anti-cancer agents. Benefits include the ease...
Tumor heterogeneity poses a great challenge for current therapeutics. The ability of cancer cells to...
Cancer is one of the leading causes of death worldwide. The development of cancer-specific diagnosti...
Peptide-based pharmaceuticals have recently experienced a renaissance due to their ability to fill t...
Accounting for 16 million new cases and 9 million deaths annually, cancer leaves a great number of p...
Many new therapies are currently being used to treat cancer. Among these new methods, chemotherapy b...
Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many organisms. Alt...
Cancer-targeting peptides as ligands for targeted delivery of anticancer drugs or drug carriers have...
Cancer is responsible for millions of immature deaths every year and is an economical burden on deve...
Cancer is responsible for millions of immature deaths every year and is an economical burden on deve...
Cancer became recently the leading cause of death in industrialized countries. Even though standard ...
Targeted delivery of chemotherapeutics and diagnostic agents conjugated to carrier ligands has made ...
The dramatic rise in cancer incidence, alongside treatment deficiencies, has elevated cancer to the ...
International audienceThis review is an attempt to illustrate the diversity of peptides reported for...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Peptide therapeutics is a promising field for emerging anti-cancer agents. Benefits include the ease...
Tumor heterogeneity poses a great challenge for current therapeutics. The ability of cancer cells to...
Cancer is one of the leading causes of death worldwide. The development of cancer-specific diagnosti...
Peptide-based pharmaceuticals have recently experienced a renaissance due to their ability to fill t...
Accounting for 16 million new cases and 9 million deaths annually, cancer leaves a great number of p...
Many new therapies are currently being used to treat cancer. Among these new methods, chemotherapy b...
Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many organisms. Alt...
Cancer-targeting peptides as ligands for targeted delivery of anticancer drugs or drug carriers have...
Cancer is responsible for millions of immature deaths every year and is an economical burden on deve...
Cancer is responsible for millions of immature deaths every year and is an economical burden on deve...
Cancer became recently the leading cause of death in industrialized countries. Even though standard ...
Targeted delivery of chemotherapeutics and diagnostic agents conjugated to carrier ligands has made ...
The dramatic rise in cancer incidence, alongside treatment deficiencies, has elevated cancer to the ...
International audienceThis review is an attempt to illustrate the diversity of peptides reported for...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Peptide therapeutics is a promising field for emerging anti-cancer agents. Benefits include the ease...
Tumor heterogeneity poses a great challenge for current therapeutics. The ability of cancer cells to...